Drugs@FDA: FDA-Approved Drugs

Home | Previous Page

Abbreviated New Drug Application (ANDA): 065180
Company: WOCKHARDT

• Other Important Information from FDA

Products on ANDA 065180

Drug Name	Active Ingredients	Strength	Dosage Form/Route	Marketing Status	TE Code	RLD	RS
CEFTRIAXONE	CEFTRIAXONE SODIUM	EQ 1GM BASE/VIAL	INJECTABLE;INJECTION	Prescription	AP	No	No

Approval Date(s) and History, Letters, Labels, Reviews for ANDA 065180

Original Approvals or Tentative Approvals

Action Date	Submission	Action Type	Submission Classification	Review Priority; Orphan Status	Letters, Reviews, Labels, Patient Package Insert	Notes	Url
05/12/2006	ORIG-1	Approval				Label is not available on this site.

Supplements

Action Date	Submission	Supplement Categories or Approval Type	Letters, Reviews, Labels, Patient Package Insert	Note	Url
01/13/2022	SUPPL-11	Labeling-Package Insert		Label is not available on this site.
09/11/2020	SUPPL-10	Labeling-Package Insert		Label is not available on this site.
09/11/2020	SUPPL-9	Labeling-Package Insert		Label is not available on this site.
03/02/2016	SUPPL-7	Labeling-Package Insert		Label is not available on this site.
03/02/2016	SUPPL-5	Labeling-Package Insert		Label is not available on this site.
08/20/2012	SUPPL-4	Labeling-Package Insert		Label is not available on this site.

Therapeutic Equivalents for ANDA 065180

CEFTRIAXONE

INJECTABLE;INJECTION; EQ 1GM BASE/VIAL
TE Code = AP

Drug Name	Active Ingredients	Strength	Dosage Form/Route	Marketing Status	RLD	TE Code	Application No.	Company
CEFTRIAXONE	CEFTRIAXONE SODIUM	EQ 1GM BASE/VIAL	INJECTABLE;INJECTION	Prescription	No	AP	065329	ACS DOBFAR
CEFTRIAXONE	CEFTRIAXONE SODIUM	EQ 1GM BASE/VIAL	INJECTABLE;INJECTION	Prescription	No	AP	065204	SANDOZ INC
CEFTRIAXONE	CEFTRIAXONE SODIUM	EQ 1GM BASE/VIAL	INJECTABLE;INJECTION	Prescription	No	AP	065180	WOCKHARDT
CEFTRIAXONE AND DEXTROSE IN DUPLEX CONTAINER	CEFTRIAXONE SODIUM	EQ 1GM BASE/VIAL	INJECTABLE;INJECTION	Prescription	Yes	AP	050796	B BRAUN